Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $235.36 USD
Change Today +0.46 / 0.20%
Volume 584.6K
VRX On Other Exchanges
New York
As of 1:22 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Key Executives - valeant pharmaceuticals inte (VRX)

NameBoard RelationshipsTitleAge
J. Michael Pearson 32 RelationshipsChairman and Chief Executive Officer56
Robert L. Rosiello No RelationshipsChief Financial Officer and Executive Vice President--
Pavel Mirovsky No RelationshipsPresident of Valeant Europe and General Manager of Valeant Europe64
Robert Roswell Chai-Onn 12 RelationshipsChief Legal Officer, Executive Vice President, Head of Corporate & Business Development and General Counsel45
Deborah A. Jorn No RelationshipsExecutive Vice President, and Company Group Chairman--

Board Members - valeant pharmaceuticals inte (VRX)

NameBoard RelationshipsPrimary CompanyAge
J. Michael Pearson 32 RelationshipsValeant Pharmaceuticals International, Inc.56
Robert N. Power 19 RelationshipsValeant Pharmaceuticals International, Inc.58
H. Christian Fibiger Ph.D.30 RelationshipsMedGenesis Therapeutix Inc.72
Norma Ann Provencio 44 RelationshipsValeant Pharmaceuticals International, Inc.58
Ronald Harold Farmer 69 RelationshipsBank of Montreal65

Executive Committees* - valeant pharmaceuticals inte (VRX)

Committee NameChairpersonBoard RelationshipsMembers
Audit CommitteeNorma Ann Provencio 44 Relationships3 Executives
Compensation CommitteeRonald Harold Farmer 69 Relationships3 Executives
Nominating CommitteeRobert N. Power 19 Relationships3 Executives
Corporate Governance CommitteeRobert N. Power 19 Relationships3 Executives
Advisory BoardH. Christian Fibiger Ph.D. 30 Relationships5 Executives
View VRX Committee Details
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VRX:US $235.36 USD +0.46

VRX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Astellas Pharma Inc ¥1,804 JPY +23.00
Bristol-Myers Squibb Co $60.10 USD -0.72
Celgene Corp $123.30 USD +0.26
Eli Lilly & Co $83.50 USD -0.24
Mylan NV $50.24 USD -1.25
View Industry Companies

Industry Analysis


Industry Average

Valuation VRX Industry Range
Price/Earnings 94.3x
Price/Sales 8.5x
Price/Book 12.1x
Price/Cash Flow 30.8x
TEV/Sales 4.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VALEANT PHARMACEUTICALS INTE, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at